Next week, 430 new laws will go into effect in Maryland, including one that sharply raises speed camera fines from a $40 flat ...
12:45 a.m. Saturday — N. Morton St. and N. Main St. A man, 61, reported having pain and injury to his elbow/lower arm. A man, ...
From cries to calm. From fear to relief. Across India, children and families are experiencing vaccines without the sting of ...
IF a health condition affects one in five Brits, you’d think most of us would have heard of it. We all know about anxiety and ...
Chiku Singh and other residents have long been funding trap-neuter-return programmes and setting up feeding stations away ...
The Grand Canyon state is home to 29 different species of bat. And while only one species — the recently discovered Mexican ...
California, Oregon, Washington and Hawaii early this month formed the West Coast Health Alliance in an effort to combat what ...
FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD
The FDA has approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya) for adults with moderately to severely ...
Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) ...
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback